Actively Recruiting
Observational Study Evaluating a Dynamic Risk Model for Severe Treatment-Related Myelosuppression in Adults with Nasopharyngeal Carcinoma
Led by Nanfang Hospital, Southern Medical University · Updated on 2026-09-15
1782
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a multicenter, prospective observational study to evaluate a dynamic risk prediction model for severe treatment-related myelosuppression in patients with nasopharyngeal carcinoma receiving systemic therapy. This model estimates the risk of serious anemia, thrombocytopenia, and leukopenia or neutropenia during treatment cycles. Adult patients with confirmed nasopharyngeal carcinoma receiving systemic anticancer therapy as part of routine clinical care will be enrolled consecutively. Clinical and laboratory data will be collected before each treatment cycle to update risk predictions. Treatment and supportive care will follow standard clinical practice, and the models predictions will be used only for research without influencing patient care. Participants will be followed through all systemic treatment cycles and for 28 days after the last treatment. Researchers will collect routine clinical and lab data during this period to evaluate the models predictive accuracy for grade 3 or higher myelosuppression. This observational approach allows monitoring without altering treatment, with the study expected to complete by June 2028.
CONDITIONS
Brief Title
Dynamic Risk Prediction of Severe Myelosuppression in Nasopharyngeal Carcinoma
Research Team
J
Jian Guan
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here